Markets open

Cencora, Inc.

COR · NYSE

Analyst Consensus

Buy

16 analysts

$319

Current

—

Low

$342

Average

—

High

Average target implies +7.11% versus the current price.

The ratings synthesis for COR has not been generated yet.

Rating Actions

No individual rating actions have been captured for CORyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Covering Firms

ARGUS RESEARCH

B OF A GLBL RES

BAIRD R W

BARCLAYS CAPITA

CITIGROUP

CO FORECST

DEUTSCHE BK SEC

EVERCORE ISI

JEFFERIES & CO.

JP MORGAN SECUR

MIZUHO SECURITI

MORGAN STANLEY

TD COWEN

UBS

WELLS FARGO SEC

ZACKS RESEARCH

Symbol: COR
Type: Stock
Sector: Health Care
Industry: Other Pharmaceuticals
Country: North America
Exchange: NYSE

Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Cencora's worldwide team members contribute to positive health outcomes through the power of Cencora's purpose: Cencora is united in its responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #17 on the Global Fortune 500 with more than $300 billion in annual revenue. Learn more at investor.cencora.com.